PSY19 A COST PER RESPONDER ANALYSIS OF SECUKINUMAB COMPARED TO OTHER BIOLOGICS FOR TREATMENT OF MODERATE TO SEVERE PSORIASIS PATIENTS OVER 1 YEAR IN MOROCCO

Category Primary study
JournalValue in Health
Year 2019
This article has no abstract
Epistemonikos ID: 89aa1eb043001a3de81912f45f223359dd87a8df
First added on: Feb 11, 2025